The Cancer Business and Laetrile: Why We Still Don't Have a Cure for Cancer

Even as a kid, Ralph Moss had held a deep admiration for the scientists dedicated to searching for a cancer cure. These researchers held a slightly higher position on his admiration scale than even the Brooklyn Dodgers could command. So it was a dream come true when in 1974, he landed a job as a science writer at the prestigious Memorial Sloan Kettering Cancer Center. To be a part of the winning team that finally defeated cancer was the ultimate achievement he could ever have hoped for.


Part of his job was to write press releases for the media about cancer news. So in the normal course of a day's work, he interviewed Dr Kanematsu Sugiura. Dr Sugiura, a widely recognized scientist with impressive credentials, had repeatedly gotten positive results shrinking tumors in mice with a natural substance called amygdalin; a substance that today is commonly known as laetrile. This event, it turned out, set him up to see a side of the cancer business he had not, in his wildest dreams, imagined.


In submitting the proposed article about Dr Sugiura's work to his superiors, he received the shock ofhis life. He was ordered to abandon the project immediately and never address it again! His objections fell on deaf ears. The validity of Dr Sugiura's work was of no consequence.


LYING TO THE PUBLIC - PART OF THE CANCER BUSINESS

Ralph Moss had been given a career ending order. He had been ordered to lie! He had been ordered to write an article and press release for all major news media, emphatically stating that amygdalin studies were negative and that the substance was worthless for cancer treatment. This under the Sloan Kettering Banner.


In the hope that the whole thing would blow over, Ralph Moss failed to comply. He had the truth in his possession. The entire situation inspired him to take a closer look at his bosses. And the nagging question haunted him: Why would anyone want to suppress such positive results of cancer research? He went on, quietly searching for answers, and his files grew thick. Here's what he learned:

• Sloan Kettering's Board of Directors was dominated by the CEOs of companies producing the worst cancer causing products on the planet.


• CEOs of the top pharmaceutical companies producing chemotherapy drugs were prominently represented on the board.


• The Sloan Kettering Hospital itself was heavily invested in these drug companies.


• Seven of the Hospital's nine members of its Institutional Policy Committee had strong ties to the pharmaceutical industry.


• Six of the Directors also served on the Boards of CBS, Warner Communications, and Reader's Digest.


• The hospital itself was heavily invested in the stock of these chemo producing drug companies.

So with the media trumpeting every new drug as a "breakthrough," in the "war on cancer," Ralph Moss came to understand very clearly how the profits from chemotherapy drugs were going through the roof. And he continued filing his notes in his office cabinet, not knowing what to do with them. He simply needed to develop an understanding of all this for himself, never entertaining any notions of disseminating any of this information publicly. And it would probably never have gotten out, had it not been for the sheer greed of his employers.


A CAREER COMES TO AN END

Even though pharmaceutical profits were skyrocketing, corporate did not fail to notice that public interest in laetrile was holding steady. They saw themselves losing market share to the laetrile clinics springing up in Mexico. And Sloan Kettering's phone lines were being tied up with callers demanding to know what the hospital thought of it. As a result, Ralph was once again ordered to write up news releases declaring that, after meticulous research and study, the institute had found laetrile to be valueless in the treatment of cancer.


To Ralph Moss, this issue was simply too big to lie about. In November of 1977, he stood up at a press conference and spelled out in painstaking detail, Memorial Sloan Kettering Cancer Center's aggressive suppression of the facts surrounding amygdalin. He explained with great care, how all the positive results obtained from their studies of laetril had been carefully held from public view.


Next day he was fired. He arrived at his office to find his files padlocked. Armed guards escorted him out. But fortunately, Ralph Moss had a savvy wife who had squirelled away copies of all his notes. They turned into his first book: The Cancer Industry.


For more on cancer and the frauds being perpetrated on us by the self serving cancer business, visit the LeQuadrillage Cancer Page. Receive unbiased and informative commentary on Health & Wellness issues with emphasis on Alternative, Complimentary, and Holistic disciplines. Find correct wellness information, given with due respect for all branches of healing. Recognition of the multitude of frauds and misapprehensions heaped on all of us by vested commercial interests, whatever their source, remains an ongoing thrust of this website. Visit us at LeQuadrillage.com - the Fulcrum for your lever to Health & Wellness. Free confidential referrals. Nothing sold directly here. Why pay for information you can get here free?